Matches in SemOpenAlex for { <https://semopenalex.org/work/W856165064> ?p ?o ?g. }
Showing items 1 to 90 of
90
with 100 items per page.
- W856165064 abstract "Introduction: A growing amount of literature in both human and animal models supports the hypothesis that chronic inflammation is a key component in cerebral aneurysm (CA) development and rupture. Aspirin has a well-documented history of safety and pharmacologic studies reveal that aspirin’s anti-inflammatory properties impede several pathways that are implicated in aneurysm growth and rupture. Recently, our secondary analysis of the International Study of Unruptured Intracranial Aneurysms showed a significant association between aspirin use and decreased incidence of subarachnoid hemorrhage. We aimed to determine whether an animal model could be used to investigate the mechanisms of aspirin’s protective effects and to refine the molecular targets for prevention of CA rupture. As an initial step, we tested whether aspirin could reduce the incidence of aneurysmal rupture in our mouse CA model. Method: We generated CAs by a combination of induced hypertension and local elastic lamina disruption. In male C57/B6 mice, systemic hypertension was induced by desoxycorticosterone acetate-salt treatment. Elastase (35mU) was injected stereotaxically in the right basal cistern to produce disruption of elastic lamina. One week after aneurysm induction surgery, mice were given 30mg/kg daily aspirin by gavage. Control animals were given the same volume of water. Aneurysmal rupture were detected by daily clinical evaluation and confirmed by brain dissection. All animals were sacrificed three weeks after elastase injection to determine rate of CA formation. Results: For the control group (N=10), 80% developed CA by 3 weeks. 40% of the control animals had ruptured aneurysm that caused neurological deficits prior the end of the study. Similarly for the aspirin group (N=10), 80% developed CA by 3 weeks. However, only 20% of the animals who received daily aspirin developed cerebral aneurysm rupture. Conclusion: Similar to our previous human epidemiological study, we observed a strong trend of lower rate of CA rupture with daily aspirin use in our animal model. Further investigations to confirm this finding and studies on the mechanistic basis of aspirin’s protective effect are underway. Using this animal model with established rates of CA development and rupture allows us to test other anti-inflammatory agents and conduct studies on specific molecular targets for the prevention of aneurysm rupture." @default.
- W856165064 created "2016-06-24" @default.
- W856165064 creator A5000625638 @default.
- W856165064 creator A5004062581 @default.
- W856165064 creator A5014880968 @default.
- W856165064 creator A5038924268 @default.
- W856165064 creator A5082611756 @default.
- W856165064 creator A5086100713 @default.
- W856165064 creator A5088068783 @default.
- W856165064 date "2012-02-01" @default.
- W856165064 modified "2023-10-16" @default.
- W856165064 title "Abstract 3678: Decreased Incidence of Cerebral Aneurysm Rupture with the use of Aspirin in an Animal Model" @default.
- W856165064 doi "https://doi.org/10.1161/str.43.suppl_1.a3678" @default.
- W856165064 hasPublicationYear "2012" @default.
- W856165064 type Work @default.
- W856165064 sameAs 856165064 @default.
- W856165064 citedByCount "0" @default.
- W856165064 crossrefType "journal-article" @default.
- W856165064 hasAuthorship W856165064A5000625638 @default.
- W856165064 hasAuthorship W856165064A5004062581 @default.
- W856165064 hasAuthorship W856165064A5014880968 @default.
- W856165064 hasAuthorship W856165064A5038924268 @default.
- W856165064 hasAuthorship W856165064A5082611756 @default.
- W856165064 hasAuthorship W856165064A5086100713 @default.
- W856165064 hasAuthorship W856165064A5088068783 @default.
- W856165064 hasConcept C10162356 @default.
- W856165064 hasConcept C120665830 @default.
- W856165064 hasConcept C121332964 @default.
- W856165064 hasConcept C126322002 @default.
- W856165064 hasConcept C141071460 @default.
- W856165064 hasConcept C164705383 @default.
- W856165064 hasConcept C172268261 @default.
- W856165064 hasConcept C181199279 @default.
- W856165064 hasConcept C185592680 @default.
- W856165064 hasConcept C2776098176 @default.
- W856165064 hasConcept C2776205367 @default.
- W856165064 hasConcept C2776820930 @default.
- W856165064 hasConcept C2777628954 @default.
- W856165064 hasConcept C2777736543 @default.
- W856165064 hasConcept C2778024521 @default.
- W856165064 hasConcept C2778117688 @default.
- W856165064 hasConcept C2779306644 @default.
- W856165064 hasConcept C2779689624 @default.
- W856165064 hasConcept C2781044401 @default.
- W856165064 hasConcept C42219234 @default.
- W856165064 hasConcept C55493867 @default.
- W856165064 hasConcept C61511704 @default.
- W856165064 hasConcept C71924100 @default.
- W856165064 hasConceptScore W856165064C10162356 @default.
- W856165064 hasConceptScore W856165064C120665830 @default.
- W856165064 hasConceptScore W856165064C121332964 @default.
- W856165064 hasConceptScore W856165064C126322002 @default.
- W856165064 hasConceptScore W856165064C141071460 @default.
- W856165064 hasConceptScore W856165064C164705383 @default.
- W856165064 hasConceptScore W856165064C172268261 @default.
- W856165064 hasConceptScore W856165064C181199279 @default.
- W856165064 hasConceptScore W856165064C185592680 @default.
- W856165064 hasConceptScore W856165064C2776098176 @default.
- W856165064 hasConceptScore W856165064C2776205367 @default.
- W856165064 hasConceptScore W856165064C2776820930 @default.
- W856165064 hasConceptScore W856165064C2777628954 @default.
- W856165064 hasConceptScore W856165064C2777736543 @default.
- W856165064 hasConceptScore W856165064C2778024521 @default.
- W856165064 hasConceptScore W856165064C2778117688 @default.
- W856165064 hasConceptScore W856165064C2779306644 @default.
- W856165064 hasConceptScore W856165064C2779689624 @default.
- W856165064 hasConceptScore W856165064C2781044401 @default.
- W856165064 hasConceptScore W856165064C42219234 @default.
- W856165064 hasConceptScore W856165064C55493867 @default.
- W856165064 hasConceptScore W856165064C61511704 @default.
- W856165064 hasConceptScore W856165064C71924100 @default.
- W856165064 hasIssue "suppl_1" @default.
- W856165064 hasLocation W8561650641 @default.
- W856165064 hasOpenAccess W856165064 @default.
- W856165064 hasPrimaryLocation W8561650641 @default.
- W856165064 hasRelatedWork W1562015762 @default.
- W856165064 hasRelatedWork W2011827672 @default.
- W856165064 hasRelatedWork W2058520121 @default.
- W856165064 hasRelatedWork W2099140264 @default.
- W856165064 hasRelatedWork W2133969699 @default.
- W856165064 hasRelatedWork W2884339443 @default.
- W856165064 hasRelatedWork W4210421850 @default.
- W856165064 hasRelatedWork W4238089809 @default.
- W856165064 hasRelatedWork W4321497469 @default.
- W856165064 hasRelatedWork W856165064 @default.
- W856165064 hasVolume "43" @default.
- W856165064 isParatext "false" @default.
- W856165064 isRetracted "false" @default.
- W856165064 magId "856165064" @default.
- W856165064 workType "article" @default.